HEALTH● LOW6h ago · Sep 14, 2026, 3:58 PM
Definium rises as LSD pill achieves primary goal in late-stage trial for anxiety
Seeking Alpha Tech · global
Definium's stock rose following the successful achievement of primary goals in a late-stage clinical trial for an LSD pill designed to treat anxiety. This indicates progress in psychedelic-assisted therapy research.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH41m ago3rd person with measles dies in PennsylvaniaCBS NewsHEALTH55m agoChile validated as first South American country to eliminate dog-transmitted rabiesABC NewsHEALTH2h ago97% of PHCs in 16 states fail national staffing standards – ReportPremium TimesHEALTH2h agoPennsylvania woman dies of measles complications, coroner reportsCBS News